Highly cell permeable purine compound that acts as a selective and ATP-competitive inhibitor of Cdks (IC=6.6M, 0.41M, 5.5M, 15M and 3.9M for Cdk1/cyclin B, Cdk2/cyclin A, Cdk4/cyclin D, Cdk5/p25 and Cdk7/cyclin H) and displays anti-cancer properties. Causes cell cycle arrest at the G2/M phase and induces apoptosis by activating caspases and downregulating survivin.

Additional Information

Product #	N-1175
CAS #	444723-13-1
Chemical Name	4-(6-Cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide
Formula	C23H30N6O2
MW	422.5
Appearance	White to off-white Solid
Purity	95% by HPLC
Solubility	Soluble in DMSO (10mg/ml).
Storage Temp	-20°C
Therapeutic Area	Oncological Disorders
Use	Cdk2 Inhibitor IV, NU6140 is a highly cell-permeable purine compound that displays anticancer properties and acts as a selective and ATP-competitive inhibitor of Cdks

Additional Information

MDL Number	MFCD09264153
ChemACX	X2273892-7
InChI	InChI=1S/C23H30N6O2/c1-3-29(4-2)22(30)17-10-12-18(13-11-17)26-23-27-20-19(24-15-25-20)21(28-23)31-14-16-8-6-5-7-9-16/h10-13,15-16H,3-9,14H2,1-2H3,(H2,24,25,26,27,28)
SMILES	CCN(CC)C(=O)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)OCC4CCCCC4)N=CN3